EPCAM and cancer: Immunizations with EVs isolated from permanent human cancer cell lines of different origins yielded many antibodies targeting membrane proteins including established TAAs like EpCAM and Her2/neu, but also against proteins which have hitherto never been described to be exposed on the cell surface.